SageView Advisory Group »

Janux Therapeutics shares owned by SageView Advisory Group

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by SageView Advisory Group from 13F filings

Historical chart of SageView Advisory Group investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by SageView Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by SageView Advisory Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $13k 950 13.80

More positions owned by SageView Advisory Group

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Extend Mkt Etf (VXF)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Ishares Tr Core Intl Aggr (IAGG)
Ishares Tr Global Reit Etf (REET)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPHY)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for SageView Advisory Group

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
State Street Corporation
Vanguard Group
Adage Capital Partners GP
Prosight Management
OrbiMed Advisors
TCG Crossover Management
Alyeska Investment Group
Geode Capital Management
Goldman Sachs Group
Woodline Partners
Logos Global Management

View all funds holding Janux Therapeutics